SMTL ID : 6dcg.1

Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: Y.193, R.197, R.200, Y.239 5 PLIP interactions: 5 interactions with chain A Water bridges: A:R.200, A:Y.239, A:Y.239 Salt bridges: A:R.197, A:R.200 SO4.2: 3 residues within 4Å: Chain A: G.188, F.189, K.265 5 PLIP interactions: 5 interactions with chain A Water bridges: A:G.188, A:G.188, A:G.188, A:F.189 Salt bridges: A:K.265

1 x G67: (3S)-3-(methylsulfanyl)-1-(2-{4-[4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]-3,6-dihydropyridin-1(2H)-yl}-2-oxoethyl)-N-(3-{6-[(propan-2-yl)oxy]pyridin-3-yl}-1H-indazol-5-yl)pyrrolidine-3-carboxamide(Non-covalent)

G67.3: 29 residues within 4Å: Chain A: I.37, A.41, Y.42, V.45, A.58, K.60, I.62, P.64, Y.70, R.73, T.74, E.77, I.90, I.109, Q.111, D.112, L.113, M.114, E.115, T.116, D.117, K.120, S.159, N.160, L.162, C.172, D.173, F.174, G.175 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:I.37, A:Y.42, A:Y.42, A:A.58, A:K.60, A:I.62, A:Y.70, A:Y.70, A:R.73, A:Q.111, A:L.162, A:L.162 Hydrogen bonds: A:K.60, A:D.112, A:M.114, A:K.120 Water bridges: A:Q.111 Salt bridges: A:E.77, A:D.173 pi-Stacking: A:Y.70

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Boga, S.B. et al., MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology. ACS Med Chem Lett (2018)

Release Date

2018-08-08

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence